Annual Total Liabilities
$33.97 M
+$10.03 M+41.88%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual total liabilities is $33.97 million, with the most recent change of +$10.03 million (+41.88%) on December 31, 2023.
- During the last 3 years, INBX annual total liabilities has fallen by -$34.29 million (-50.24%).
- INBX annual total liabilities is now -71.70% below its all-time high of $120.06 million, reached on December 31, 2019.
Performance
INBX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$44.09 M
+$5.04 M+12.91%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly total liabilities is $44.09 million, with the most recent change of +$5.04 million (+12.91%) on September 30, 2024.
- Over the past year, INBX quarterly total liabilities has increased by +$5.04 million (+12.91%).
- INBX quarterly total liabilities is now -81.86% below its all-time high of $243.14 million, reached on September 30, 2023.
Performance
INBX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
INBX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.9% | +12.9% |
| 3 y3 years | -50.2% | -81.5% |
| 5 y5 years | -49.8% | -81.5% |
INBX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.4% | +41.9% | -81.9% | +29.8% |
| 5 y | 5-year | -71.7% | +41.9% | -81.9% | +29.8% |
| alltime | all time | -71.7% | +41.9% | -81.9% | +29.8% |
Inhibrx Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.09 M(+12.9%) |
| Jun 2024 | - | $39.05 M(+0.2%) |
| Mar 2024 | - | $38.99 M(+14.8%) |
| Dec 2023 | $33.97 M(+41.9%) | $33.97 M(-86.0%) |
| Sep 2023 | - | $243.14 M(+2.2%) |
| Jun 2023 | - | $237.98 M(-0.3%) |
| Mar 2023 | - | $238.58 M(+2.5%) |
| Dec 2022 | $23.95 M(-75.6%) | $232.82 M(+16.5%) |
| Sep 2022 | - | $199.90 M(+0.9%) |
| Jun 2022 | - | $198.13 M(+48.0%) |
| Mar 2022 | - | $133.83 M(+36.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $98.07 M(+43.7%) | $98.07 M(-2.9%) |
| Sep 2021 | - | $100.98 M(+3.5%) |
| Jun 2021 | - | $97.57 M(+52.7%) |
| Mar 2021 | - | $63.91 M(-6.4%) |
| Dec 2020 | $68.27 M(-43.1%) | $68.27 M(+31.7%) |
| Sep 2020 | - | $51.83 M(+27.8%) |
| Jun 2020 | - | $40.55 M(-66.2%) |
| Dec 2019 | $120.06 M(+77.5%) | $120.06 M(+11.2%) |
| Jun 2019 | - | $107.98 M(+27.6%) |
| Mar 2019 | - | $84.61 M |
| Dec 2018 | $67.63 M(+70.5%) | - |
| Dec 2017 | $39.67 M | - |
FAQ
- What is Inhibrx Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual total liabilities year-on-year change?
- What is Inhibrx Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly total liabilities year-on-year change?
What is Inhibrx Biosciences annual total liabilities?
The current annual total liabilities of INBX is $33.97 M
What is the all time high annual total liabilities for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual total liabilities is $120.06 M
What is Inhibrx Biosciences annual total liabilities year-on-year change?
Over the past year, INBX annual total liabilities has changed by +$10.03 M (+41.88%)
What is Inhibrx Biosciences quarterly total liabilities?
The current quarterly total liabilities of INBX is $44.09 M
What is the all time high quarterly total liabilities for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly total liabilities is $243.14 M
What is Inhibrx Biosciences quarterly total liabilities year-on-year change?
Over the past year, INBX quarterly total liabilities has changed by +$5.04 M (+12.91%)